Overview

Sirolimus for Retinal Astrocytic Hamartoma

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
0
Participant gender:
Male
Summary
A single patient study using intravitreal Sirolimus to treat a patient with multiple retinal astrocytic hamartomas (RAH) of both eyes.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The Hospital for Sick Children
Treatments:
Sirolimus
Criteria
Single case diagnosed with multiple retinal astrocytic hamartomas (RAH) of both eyes with
imminent threat to vision.